Anatole Ghazalpour
Overview
Explore the profile of Anatole Ghazalpour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
2867
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Topcagic J, Feldman R, Ghazalpour A, Swensen J, Gatalica Z, Vranic S
PLoS One
. 2018 Jan;
13(1):e0191244.
PMID: 29324814
Olfactory neuroblastoma (ONB) is a rare, locally aggressive, malignant neoplasm originating in the olfactory epithelium in the nasal vault. The recurrence rate of ONB remains high and there are no...
2.
Hartiala J, Schwartzman W, Gabbay J, Ghazalpour A, Bennett B, Allayee H
Curr Atheroscler Rep
. 2017 Jan;
19(2):6.
PMID: 28130654
Purpose Of Review: We provide an overview of our current understanding of the genetic architecture of coronary artery disease (CAD) and discuss areas of research that provide excellent opportunities for...
3.
Xiu J, Piccioni D, Juarez T, Pingle S, Hu J, Rudnick J, et al.
Oncotarget
. 2016 Mar;
7(16):21556-69.
PMID: 26933808
Glioblastomas (GBM) are the most aggressive and prevalent form of gliomas with abysmal prognosis and limited treatment options. We analyzed clinically relevant molecular aberrations suggestive of response to therapies in...
4.
Ghazalpour A, Cespedes I, Bennett B, Allayee H
Curr Opin Lipidol
. 2016 Feb;
27(2):141-7.
PMID: 26855231
Purpose Of Review: This article highlights recent advances in the emerging role that gut microbiota play in modulating metabolic phenotypes, with a particular focus on lipid metabolism. Recent Findings: Accumulating...
5.
Gatalica Z, Vranic S, Ghazalpour A, Xiu J, Ocal I, McGill J, et al.
Oncotarget
. 2015 Dec;
7(2):1707-16.
PMID: 26625196
Malignant phyllodes tumor is a rare breast malignancy with sarcomatous overgrowth and with limited effective treatment options for recurrent and metastatic cases. Recent clinical trials indicated a potential for anti-angiogenic,...
6.
Wen W, Chen W, Xiao N, Bender R, Ghazalpour A, Tan Z, et al.
J Mol Diagn
. 2015 Sep;
17(5):487-95.
PMID: 26320869
The HER2 (official name ERBB2) gene encodes a membrane receptor in the epidermal growth factor receptor family amplified and overexpressed in adenocarcinoma. Activating mutations also occur in several cancers. We...
7.
Zhou X, Crow A, Hartiala J, Spindler T, Ghazalpour A, Barsky L, et al.
Stem Cell Reports
. 2015 Jun;
5(1):125-38.
PMID: 26050929
Prior efforts to identify regulators of hematopoietic stem cell physiology have relied mainly on candidate gene approaches with genetically modified mice. Here we used a genome-wide association study (GWAS) strategy...
8.
Orozco L, Morselli M, Rubbi L, Guo W, Go J, Shi H, et al.
Cell Metab
. 2015 Jun;
21(6):905-17.
PMID: 26039453
Heritable epigenetic factors can contribute to complex disease etiology. Here we examine the contribution of DNA methylation to complex traits that are precursors to heart disease, diabetes, and osteoporosis. We...
9.
Gatalica Z, Snyder C, Maney T, Ghazalpour A, Holterman D, Xiao N, et al.
Cancer Epidemiol Biomarkers Prev
. 2014 Nov;
23(12):2965-70.
PMID: 25392179
Cancer cells expressing PD-1 ligands (PD-L1/PD-L2) inhibit immune-modulatory T-cell activation facilitating disease progression. Preliminary clinical trials exploring interruption of PD-1/PD-L1 signaling showed benefit in several cancer types. We analyzed the...
10.
Sirintrapun S, Geisinger K, Cimic A, Snow A, Hagenkord J, Monzon F, et al.
Medicine (Baltimore)
. 2014 Oct;
93(15):e81.
PMID: 25275525
Renal oncocytoma is a benign tumor with characteristic histologic findings. We describe an oncocytoma-like renal tumor with progression to high-grade oncocytic carcinoma and metastasis. A 74-year-old man with no family...